Home LiteratureArticle Details
PMID: 6744777 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

The diltiazem-digoxin interaction.

Clinical pharmacology and therapeutics ·Vol. 36 ·No. 2 ·1984-08-00 ·Pages 183-9

Rameis H, Magometschnigg D, Ganzinger U

Abstract

To study the interaction between the calcium antagonist diltiazem and digoxin, a randomized crossover trial under steady-state conditions was carried out in 24 healthy male subjects. Diltiazem with digoxin induced an average increase of steady-state plasma digoxin concentration and AUC over 48 hr of 22.4%. This is caused by the prolongation of elimination t1/2 from 36.2 +/- 11.2 to 44.5 +/- 11.5 hr (means +/- SD) and the impairment of total digoxin clearance, dropping from 146.6 +/- 37.9 to 107.9 +/- 18.4 ml/min. Average reduction in renal clearance (from 102.1 +/- 35.5 to 85.5 +/- 42.7 ml/min) was not statistically reproducible. Apparent volume of distribution was not relevantly altered. Diltiazem kinetics did not change significantly when digoxin was concurrently given.

MeSH Terms
Adult Benzazepines/pharmacology Digoxin/metabolism Diltiazem/pharmacology Drug Interactions Humans Kinetics Male Metabolic Clearance Rate Protein Binding
Chemicals
Benzazepines Digoxin Diltiazem
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rameis H
Magometschnigg D
Ganzinger U
Article Info
Journal
Clinical pharmacology and therapeutics
Abbr.
Clin Pharmacol Ther
ISSN
0009-9236
Published
1984-08-00
Pages
183-9
Language
English
Region
United States
NLM ID
0372741
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com